Jones Financial Companies
LXRX icon

Jones Financial Companies’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jones Financial Companies’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908 Hold
356
– – ﹤0.01% 4623
2026
Q1 		$587 Sell
356
-750
-68% -$1.09K ﹤0.01% 4463
2025
Q4 		$1.27K Buy
1,106
+214
+24% +$294 ﹤0.01% 3960
2025
Q3 		$1.25K Sell
892
-1,150
-56% -$1.3K ﹤0.01% 3841
2025
Q2 		$1.67K Hold
2,042
– – ﹤0.01% 3524
2025
Q1 		$1.16K Buy
2,042
+1,900
+1,338% +$1.2K ﹤0.01% 3367
2024
Q4 		$105 Buy
+142
New +$171 ﹤0.01% 3348

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jones Financial Companies's LXRX Position: Q2 2026 in Review

Jones Financial Companies held its Lexicon Pharmaceuticals (LXRX) position steady in Q2 2026 at 356 shares worth $908. The position accounts for ﹤0.01% of the portfolio, ranked #4623.

Jones Financial Companies first reported a position in LXRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.67K in Q2 2025. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Jones Financial Companies held 356 shares of Lexicon Pharmaceuticals worth $908 as of Q2 2026.
  • Jones Financial Companies left its Lexicon Pharmaceuticals share count unchanged in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4623 holding.
  • Jones Financial Companies first reported a position in Lexicon Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Jones Financial Companies's Lexicon Pharmaceuticals position peaked at $1.67K in Q2 2025.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.